Elevated plasma levels of PAI|1 predict cardiovascular events and ...

Elevated plasma levels of PAI-1 predict cardiovascular events and ...

Elevated plasma levels of PAI-1 predict cardiovascular events and cardiovascular mortality in prevalent peritoneal dialysis patients · Authors · Affiliation.

Elevated Plasma Levels of PAI-1 Predict Cardiovascular Events and ...

Background. Elevated plasminogen activator inhibitor-1 (PAI-1) levels are associated with increased cardiovascular (CV) risk in the general population. It has ...

Elevated Plasma Levels of PAI-1 Predict Cardiovascular Events and ...

Elevated plasminogen activator inhibitor-1. (PAI-1) levels are associated with increased cardiovascular (CV) risk in the general population. It has been shown ...

Blood PAI-1 and cardiovascular and metabolic risk factors among ...

Multivariable linear regression models still indicated that increased blood PAI-1 levels were associated with higher cardiovascular and ...

Plasminogen Activator Inhibitor and the Risk of Cardiovascular ...

PAI-1 and TPA antigen levels are predictive of CVD events after accounting for established risk factors. A serial increase in PAI-1 is associated with a further ...

Association between plasminogen activator inhibitor-1 and ...

Elevated plasma PAI-1 antigen levels are associated with MACE. Definitive studies are needed to ascertain if PAI-1 acts simply as a marker of ...

High Plasminogen Activator Inhibitor and Tissue ... - AHA Journals

Conclusions—The plasma levels of PAI-1, tPA, and vWF are associated with subsequent development of a first AMI; for PAI-1 and tPA, this relation ...

Plasminogen activator inhibitor and the risk of cardiovascular disease

PAI-1 and TPA antigen levels are predictive of CVD events after accounting for established risk factors. A serial increase in PAI-1 is associated with a further ...

Clinical Plasminogen Activator Inhibitor-1–Positive Platelet-Derived ...

Elevated PAI-1+ PEV levels were predictive of 1-year major adverse cardiac events in both the discovery and the validation cohort, with larger effect sizes than ...

Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary ...

Population studies have reported that blood PAI‐1 levels are associated with increased risk of coronary heart disease (CHD). However, it is ...

The plasminogen activator inhibitor-1 −675 4G/5G genotype ...

For both cases and controls plasma PAI-1 concentrations were significantly higher in the North than the South, and in both regions were higher in individuals ...

Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into ...

Elevated levels of PAI-1 downregulate tPA and uPA activity and create a prothrombotic or hypofibrinolytic state that was suggested to contribute to the ...

Plasminogen activator inhibitor-1, inflammation, obesity, insulin ...

Elevated plasma plasminogen activator inhibitor-1 (PAI-1) level is a core feature of insulin-resistance syndrome (IRS). Atherothrombotic complications in ...

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in ...

Similarly, elevated plasma concentrations of PAI-1 seem to be linked to an increased risk of thrombotic vascular events and associated with development of ...

A Serpin With a Finger in Many PAIs: PAI-1's Central Function in ...

Increased serum levels of PAI-1 have been noted in patients with atherosclerotic disease, including coronary artery disease (40) and stroke (41). A recent large ...

Prognostic Value of Plasma Fibrinolysis Activation Markers in ...

There is evidence that TPA levels predict cardiovascular disease in apparently healthy individuals. In a prospective study of 3,582 women ages ...

Elevated Plasma Levels of PAI-1 Predict Cardiovascular Events and ...

Elevated Plasma Levels of PAI-1 Predict Cardiovascular Events and Cardiovascular Mortality in Prevalent Peritoneal Dialysis Patients.

Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular ...

The levels of B-type natriuretic peptide and N-terminal pro–atrial natriuretic peptide strongly predicted the risk of heart failure, with an increase in the ...

REVIEW: Plasminogen Activator Inhibitor‐1 (PAI‐1): A Key Factor ...

In fact, it has been demonstrated that fibrinolytic dysfunction (defined by PAI-1 levels) mediates the increased risk of cardiovascular disease ...

Elevated Levels of Acute-Phase Proteins and Plasminogen Activator ...

Chronic inflammation emerges as a new risk factor for the development of type 2 diabetes; PAI-1 predicts type 2 diabetes independent of insulin resistance.